Answers are grounded in this paper and cite their sources.
The translation of electrochemical aptamer-based (EAB) sensors into real-world applications, including continuous therapeutic drug monitoring, remains limited by low sensitivity and poor stability in physiological conditions. EAB sensors typically rely on a single redox reporter covalently attached to the aptamer to transduce target-induced conformational changes into an electrochemical signal. To date, efforts to improve EAB sensor performance have focused on aptamer engineering, optimizing immobilization and backfilling strategies, and selection of redox reporters. However, strategies capable of enhancing sensitivity beyond this established single-reporter configuration remain limited. Here, we report a dual-reporter EAB sensing strategy that exploits microenvironmental changes around two redox reporters within the sensing layer to improve vancomycin detection. The sensing interface combines an Os(II)-labeled vancomycin aptamer and a surface-immobilized MB moiety covalently anchored to an alkanethiol-based mixed monolayer. We propose that the vancomycin-induced conformational change in the aptamer modulates the local redox environment of the Os(II) complex and MB. Upon target binding, the square-wave voltammetric currents of both redox reporters decrease concomitantly, resulting in a dual-signal-OFF response with enhanced analytical performance. The proposed system achieves a 19-fold lower limit of detection than the corresponding single-reporter configuration using the Os(II)-labeled aptamer. Overall, these results identify a powerful and underexplored signal-transduction mechanism, introducing a new design paradigm for enhancing the sensitivity of EAB sensors.
No takes yet. Share an insight, caveat, or question.
Montón−Vicente et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: